Home » Drug Intermediates

Drug Intermediates

We are one of the leading manufacturer and supplier of a wide range of Drug Intermediates like: 3(3-Chloropropyl)-2,3 dihydro 1H benzimidazol -2-one, 8-Chloro-6,11 dihydro-11-(1-methyl-4-pipyridinyl)-5H benzo [5,6] cyclohepta [1,2b] pyridin -11-ol, Dibenzosuberone, N-Methyl-4-chloro piperidine, Formamidine Acetate, 3-Methylamino-propionitrile. These are used to preform drug interaction activity which formed in new Chemical Products. Our range of drug intermediates is appreciated for its purity and effectiveness.

Name of Product	CAS NO.
3(3-Chloropropyl)-2,3 dihydro 1H benzimidazol -2-one	62780-89-6
5-Chloro 2,3 dihydro -1- (4-piperidinyl) -1H- benzimidazol - 2 -one	53789-28-0
3(2-(3-Chloro phenyl)ethyl) cyano pyridine	31255-55-7
8-Chloro-5,6 dihydro(1H)-benzo[5,6] cyclohepta (1,2b) pyridin -11-one	31251-41-9
8-Chloro-6,11 dihydro-11-(1-methyl-4-pipyridinyl)-5H benzo [5,6] cyclohepta [1,2b] pyridin -11-ol	38089-93-9
11-[(N-methyl)-4-piperidylidene]-8chloro-6, 11-dihydro-5H-benzo [5,6]cyclohepta (1,2b) Pyridine (Methyl Loratadine)	38092-89-6
3(2-(3-Chloro phenyl)ethyl) cyano pyridine	255861-48-4
N-Methyl-4-chloro piperidine	5570-77-4
Dibenzosuberone	1210-35-1
3-(Di Methyl amino) propylchloride HCl	5407-04-5
2-Butyl-4-chloro-5-formyl imidazole	857-96-9
2n-Butyl-4-chloro-[1-(2’-cyanobiphenyl-4-yl) methyl]-5-(hydroxymethyl) -imidazole	114772-55-3
2-(chloromethyl)-4-methoxy-3, 5-dimethylpyridine hydrochloride	86604-75-3
3,4 Dimethoxy-2-chloromethyl pyridine Hydrochloride	72830-09-2
2-(Chloromethyl)-3-methyl-4-(2,2,2-Tri fluoro ethoxy) pyridine Hydrochloride	127337-60-4
2-[4-(aminomethyl)phenoxy]-N,N-dimethyl ethanamine	127337-60-4
(S)-(+)N,N-Dimethyl-3-(1-napthalenyloxy)-3-(2-thieyl)propanamine	132335-47-8
(S)-(-)N,N-dimethyl-3-hydroxy 3-(2-thieyl)propanamine	132335-44-5
2-Chloro-N-(2-cyclo propylamino-4-methyl-3-pyridine carboxamde	133627-47-1
2-Chloro-N-(2-chloro-4-methyl-3-pyridine carboxamde	133627-46-0
3-amino-2-Chloro-4-methyl pyride	133627-45-9
1-[2(2-Hydroxy ethoxy) ethyl]Piperazine	13349-82-1
N-[dibenzo-[b,f][1,4]thiazepin-11-Y1] Piperazine Hyderachloride	11974-74-4
Dibenzo-[b,f][1,4]Thiazepin-11(10H)-one	3159-07-7
1-(2,3-Dichlorophenyl)piperazine hydrochloride	119532-26-2
1-(4-methoxy phenyl)piperazine dihydrocholoride	38869-47-5
2,4-Dihydro-4-[4-[(4-methoxy phenyl)-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4 triazol-3-one	-
2,4-Dihydro-4-[4-[(4-Hydroxy phenyl)-1-piperazinyl]phenyl]-2-(1-methylpropy)-3H-1,2,4 triazol-3-one	89848-21-5
Cis[2-(Bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl benzoate	61397-56-6
Cis-(2,4-(dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)1,3-dioxolan-4-yl]methyl p-Toluenesulfonate	103661-14-9
Cis-(2,4-(dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)1,3-dioxolan-4-yl]methyl methanesulfonate	67914-86-7
Formamidine Acetate	3473-63-0
4-(4-hydroxyphenyl)-1-(1-methylethyl)piperazine	67914-97-0]
1-(4-Chlorophenyl)-N-Formyl-a-(2-Methylpropyl)Cyclobutane Methanamine	67914-97-0
1-(4-Chlorophenyl)-a-(2-Methylpropyl)Cyclobutane Methanamine Hydrochloride	84484-78-6
7-Hydroxy-3,4-dihydro-1H-quinolin-2-one(OR) 7-Hydroxy-3,4-Dihydro Carbostyril	22246-18-0
7-(4-Bromobutoxy)-1,2,3,-tetrahydroquinoline-2-one	-
D-(-)-Diethyl tartrate	13811-71-7
2-[[[4-(3-Methoxy Propoxy)-3-Methyl-2Pyridyl]Methyl]Thio]-1H-Benzimidazole	117977-21-6
2-Chloromethyl-4-(3-Methoxy Propoxy)-3-methyl Pyridine Hydrochloride	153259-31-5
2-Choloromethy-3-methyl-4-(2,2,2-trifluroethoxy)pyridine hydrochloride	127337-60-4
3-Methylamino-propionitrile	693-05-0
3-[(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]-propionitrile	-
Tetrahydro-furan-2-carboxylic acid {3-[(4-amino-6,7 dimethoxy-quinazolin-2-yl) meyl-amino]propyl}-amide[Alfuzosin Base]	81403-80-7
1-[(2,3-Dihyro-1,4-benzodioxan-2-yl) carbonyl] piperazine	70918-00-2
1H-Benzimidazole-2-n-propyl-4-methyl-6-(1'methyl benzimidazole-2'yl)	152628-02-9]
4,4'-Diiodobiphenyl	3001-15-8
4,4'-Dibromobiphenyl	92-86-4

Yes! I am Interested

Piperacillin & Tazobactam For Injections

Composition:	Each vial contains: piperacillin sodium USP, Eq. to piperacillin 4 g, tazobactam sodium, Eq. to tazobactam 0.5 g
Pharmacological classification:	Antibacterial
Mechanism of action:	Piperacillin, a broad spectrum, semisynthetic penicillin exerts bactericidal activity by inhibition of both septum and cell wall synthesis. Tazobactam, a beta-lactam structurally related to penicillins, is an inhibitor of many beta- lactamases, which commonly cause resistance to penicillins and cephalosporins but it does not inhibit AmpC enzymes or metallo beta-lactamases. Tazobactam extends the antibiotic spectrum of Piperacillin to include many beta-lactamase- producing bacteria that have acquired resistance to Piperacillin alone.
Indications and usage:	Yashipiptaz is used in the management of neutropenic patients with fever suspected to be due to a bacterial infection. Yashipiptaz is indicated for the treatment of the following infections in adults and children over 2 years of age Adults and adolescents: Severe pneumonia including hospital-acquired and ventilator-associated pneumonia Complicated urinary tract infections (including pyelonephritis) Complicated intra-abdominal infections Complicated skin and soft tissue infections (including diabetic foot infections) Children 2 to 12 years of age: Complicated intra-abdominal infections
Dosage and administration:	Yashipiptaz is administered by intravenous injection (over 30 minutes). The dose and frequency of Yashipiptaz depends on the severity and localization of the infection and expected pathogens. Adult and adolescent patients: For Infections: The usual dose of 4g piperacillin /0.5g tazobactam is given every eight hours. For nosocomial pneumonia & bacterial infections in neutropenic patients: Recommended dose of 4g piperacillin /0.5g tazobactam is every six hours. This regimen may also be applicable to treat patients with other indicated infections when particularly severe. For patients on haemodialysis, one additional dose of piperacillin/tazobactam 2g/0.25g should be administered following each dialysis period. No dose adjustment is required for the elderly with normal renal function or creatinine clearance values above 40 mL/min. Children: YASHIPIPTAZ is not recommended for children below 2 years age. Neutropenic children with fever suspected due to bacterial infections: 80mg Piperacillin/10mg tazobactam per kg body weight, every six hours; not to exceed the maximum 4g /0.5g per dose over 30 minutes. Complicated intra-abdominal infections: 100mg piperacillin/12.5mg tazobactam per kg body weight, every eight hours; not to exceed the maximum 4g/0.5g per dose over 30 minutes. Creatinine Clearance = 50 mg/mL: 70mg piperacillin/8.75mg tazobactam per kg body weight, every eight hours. For children on haemodialysis, one additional dose of 40mg piperacillin /5mg tazobactam per kg should be administered following each dialysis period.